In a press release, ADM said the acquisiton is continuation of an ongoing strategy, which has seen the Chicago-based firm expand probiotic manufacturing at a facility in Spain as well acquire Protexin and Biopolis. It’s part of move to take a bigger share of what ADM says is a massive global maket for health & wellness products.
“The microbiome represents one of ADM’s six strategic growth platforms, and with global demand for health and wellness products estimated at more than $775 billion, today’s investment represents a significant step forward for ADM,” said ADM Chairman and CEO Juan Luciano.
“Deerland Probiotics & Enzymes is a leader in probiotic, prebiotic and enzyme technology, with global sales and manufacturing in the U.S. and Europe, and is a perfect fit for our growing portfolio of functional ingredients and solutions for health-conscious consumers. We expect the addition of the Deerland capabilities and portfolio to deliver synergies for our Health & Wellness business and support growth across our Nutrition business unit.”
Among ADM’s earlier forays into supplement ingredients was a deal to bring an algal DHA to market. That has now blossomed into a full line of omega-3 ingredients from algae and flax ingredients.